Farmacoriflessioni
Decongestionanti nasali: nei bambini i rischi superano i benefici
Gruppo di Lavoro sui Farmaci pediatrici (AIFA)
Maggio 2007 - pagg. 309 -315
Parole chiave
Suggerite dall'AI
Classificazione MeSH
Bibliografia
1. Graf P. Rhinitis medicamentosa: a review of
causes and treatment. Treat Respir Med 2005;
4:21-9.
2. Dushay ME, Johnson CE. Management of allergic rhinitis: focus on Intranasal Agents. Pharmacotherapy 1989:9:338-50.
3. Arora P, Sharma S, Garg S. Permeability issue in nasal drug delivery. Drug Discov Today 2002;7:967-75.
4. Smith MBH, Feldman W. Over the counter cold medications: a critical review of clinical trials between 1950 and 1991. JAMA 1993;269: 2258-63.
5. Taverner D, Latte J. Nasal decongestionants for the common cold. Cochrane Database Syst Rev 2007. Issue 1.
6. Bucaretchi F, Dragosavac S, Vieira RJ. Acute exposure to imidazoline derivatives in children. Jornal de Pediatria (Rio J) 2003;79:519-24.
7. Michel O, Essers S, Heppt WJ, et al. The value of EmsMineral Salts in the treatment of rhinosinusitis in children. Prospective study on the efficacy of mineral salts versus xylometazoline in the topical nasal treatment of children. Int J Pediatr Otorhinolaryngol 2005; 69:1359-65.
8. Mahieu LM, Rooman RP, Goossens E. Imidazoline intoxication in children. Eur J Pediatr 1993;152:944-6.
9. Daggy A, Kaplan R, Roberge R, Akhtar J. Pediatric Visine® (tetrahydrozoline) ingestion: case report and review of imidazoline toxicity. Vet Human Toxicol 2003; 45: 210-2.
10. Vitezic D, Rozmanic V, Franulovic J, Ahel V, Matesic D. Naphazoline nasal drops intoxication in children. Arh Hig Rada Toksikol 1994;45:25-9.
11. Saken R, Kates GL, Miller K. Drug-induced hypertension in infancy. J Pediatr 1979;95: 1077-9.
12. BIF 2/2005.
13. Claudet I, Fries F. Danger of nasal vasoconstrictors in infants. Apropos of a case. Arch Pediatr 1997;4:538-41.
14. Musshoff F, Gerschlauer A, Madea B. Naphazoline intoxication in a child: a clinical and forensic toxicological case. Forensic Sci Int 2003;134:234-7.
15. Eti S, Cakar N, Esen F. Nose drops may cause intoxication. Sendrom 1994;6:71-2.
16. Jensen P, Edgren B, Hall L, Ring JC. Hemodynamic effects following ingestion of an imidazoline-containing product. Emergency Care 1989;5:110-2.
17. Stamer UM, Buderus S, Wetegrove S, Lentze MJ, Stuber F. Prolonged awakening and pulmonary edema after general anesthesia and naphazoline application in an infant. Anesth Analg 2001;93:1162-4.
18. Kelly LF. Pediatric cough and cold preparations. Pediatr Rev 2004;25:115-23.
19. Centers for Disease Control and Prevention (CDC). Infant death associated with cough and cold medications. Two states, 2005. MMWR Morb Mortal Wkly Rep 2007;56:1-4.
20. Food and Drug Administration. Cold, cough, allergy, bronchodilator, and antihistaminic drug products for over the counter human use. 21 CRF Part 341 (2006).
2. Dushay ME, Johnson CE. Management of allergic rhinitis: focus on Intranasal Agents. Pharmacotherapy 1989:9:338-50.
3. Arora P, Sharma S, Garg S. Permeability issue in nasal drug delivery. Drug Discov Today 2002;7:967-75.
4. Smith MBH, Feldman W. Over the counter cold medications: a critical review of clinical trials between 1950 and 1991. JAMA 1993;269: 2258-63.
5. Taverner D, Latte J. Nasal decongestionants for the common cold. Cochrane Database Syst Rev 2007. Issue 1.
6. Bucaretchi F, Dragosavac S, Vieira RJ. Acute exposure to imidazoline derivatives in children. Jornal de Pediatria (Rio J) 2003;79:519-24.
7. Michel O, Essers S, Heppt WJ, et al. The value of EmsMineral Salts in the treatment of rhinosinusitis in children. Prospective study on the efficacy of mineral salts versus xylometazoline in the topical nasal treatment of children. Int J Pediatr Otorhinolaryngol 2005; 69:1359-65.
8. Mahieu LM, Rooman RP, Goossens E. Imidazoline intoxication in children. Eur J Pediatr 1993;152:944-6.
9. Daggy A, Kaplan R, Roberge R, Akhtar J. Pediatric Visine® (tetrahydrozoline) ingestion: case report and review of imidazoline toxicity. Vet Human Toxicol 2003; 45: 210-2.
10. Vitezic D, Rozmanic V, Franulovic J, Ahel V, Matesic D. Naphazoline nasal drops intoxication in children. Arh Hig Rada Toksikol 1994;45:25-9.
11. Saken R, Kates GL, Miller K. Drug-induced hypertension in infancy. J Pediatr 1979;95: 1077-9.
12. BIF 2/2005.
13. Claudet I, Fries F. Danger of nasal vasoconstrictors in infants. Apropos of a case. Arch Pediatr 1997;4:538-41.
14. Musshoff F, Gerschlauer A, Madea B. Naphazoline intoxication in a child: a clinical and forensic toxicological case. Forensic Sci Int 2003;134:234-7.
15. Eti S, Cakar N, Esen F. Nose drops may cause intoxication. Sendrom 1994;6:71-2.
16. Jensen P, Edgren B, Hall L, Ring JC. Hemodynamic effects following ingestion of an imidazoline-containing product. Emergency Care 1989;5:110-2.
17. Stamer UM, Buderus S, Wetegrove S, Lentze MJ, Stuber F. Prolonged awakening and pulmonary edema after general anesthesia and naphazoline application in an infant. Anesth Analg 2001;93:1162-4.
18. Kelly LF. Pediatric cough and cold preparations. Pediatr Rev 2004;25:115-23.
19. Centers for Disease Control and Prevention (CDC). Infant death associated with cough and cold medications. Two states, 2005. MMWR Morb Mortal Wkly Rep 2007;56:1-4.
20. Food and Drug Administration. Cold, cough, allergy, bronchodilator, and antihistaminic drug products for over the counter human use. 21 CRF Part 341 (2006).
Corrispondenza: f.rocchi@aifa.gov.it